A COMBINATION OF STEM-CELL FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR ENHANCES THE GROWTH OF HUMAN PROGENITOR B-CELLS SUPPORTED BY MURINE STROMAL CELL-LINE MS-5
M. Nishihara et al., A COMBINATION OF STEM-CELL FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR ENHANCES THE GROWTH OF HUMAN PROGENITOR B-CELLS SUPPORTED BY MURINE STROMAL CELL-LINE MS-5, European Journal of Immunology, 28(3), 1998, pp. 855-864
We have developed a long-term culture system using the murine bone mar
row stromal cells MS-5 to support the growth of progenitor B cells wit
h CD34(-), CD10(+), CD19(+), and cytoplasmic mu chain (C mu)-negative
surface phenotype from human CD34(+) cells purified from umbilical cor
d blood (CB). When 10(3) CB CD34(+) cells/well were seeded on MS-5 str
omal cells at the beginning of culture in the absence of exogenously a
dded cytokines, progenitor B cells first appeared after 14 days, and t
he maximal cell production was achieved during the 6th week of culture
. Intriguingly, the addition of recombinant human stem cell factor (rh
SCF) and granulocyte colony-stimulating factor (rhG-CSF), but not rhIL
-7, strikingly enhanced the growth of progenitor B cells from CB CD34(
+) population cultured on MS-5 stromal cells. The culture of progenito
r B cells could be maintained until the 6th week of culture when some
cells were revealed to have a C mu(+) phenotype, and a small number of
cells had immunoglobulin Ir chain on their cell surface in the presen
ce of both rhSCF and rhG-CSF. When CD34(+) cells were cultured physica
lly separated from the stromal layer by membrane, supportive effects o
f MS-5 stromal cells for the growth of progenitor B cells were not obs
erved. These results suggest that the present culture system could gen
erate progenitor B cells to proliferate from CB CD34(+) cells, that so
me of these progenitor B cells could differentiate into immature B cel
ls in conjunction with rhSCF and rhG-CSF, and that a species-cross-rea
ctive membrane-bound factor(s), which stimulates early human B lymphop
oiesis, may exist in MS-5 stromal cells. Further studies are required
to investigate the mechanism how rhG-CSF acts on progenitor B cells to
allow their proliferation and differentiation.